Literature DB >> 7528940

Functional isolation and characterization of human hematopoietic stem cells.

A C Berardi1, A Wang, J D Levine, P Lopez, D T Scadden.   

Abstract

Hematopoietic cells differentiate in steps marked by the acquisition or loss of specific phenotypic characteristics. Human bone marrow cells that were responsive to the early-acting cytokines Kit ligand and interleukin-3 were forced to a metabolic death. The subfraction remaining represented 1 in 10(5) bone marrow mononuclear cells, were determined to be quiescent by cell cycle analysis, and had a stem cell immunophenotype. The cells were highly enriched for long-term culture-initiating cells, were capable of secondary colony formation, and produced both myeloid and lymphoid progeny. Thus, this technically simple strategy led to the efficient purification of cells with characteristics of hematopoietic stem cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7528940     DOI: 10.1126/science.7528940

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  56 in total

1.  Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.

Authors:  T Ponomaryov; A Peled; I Petit; R S Taichman; L Habler; J Sandbank; F Arenzana-Seisdedos; A Magerus; A Caruz; N Fujii; A Nagler; M Lahav; M Szyper-Kravitz; D Zipori; T Lapidot
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 2.  Quantitative modeling of chronic myeloid leukemia: insights from radiobiology.

Authors:  Tomas Radivoyevitch; Lynn Hlatky; Julian Landaw; Rainer K Sachs
Journal:  Blood       Date:  2012-02-21       Impact factor: 22.113

Review 3.  Challenges in cardiac tissue engineering.

Authors:  Gordana Vunjak-Novakovic; Nina Tandon; Amandine Godier; Robert Maidhof; Anna Marsano; Timothy P Martens; Milica Radisic
Journal:  Tissue Eng Part B Rev       Date:  2010-04       Impact factor: 6.389

Review 4.  Chemoprotection of normal tissues by transfer of drug resistance genes.

Authors:  J A Rafferty; I Hickson; N Chinnasamy; L S Lashford; G P Margison; T M Dexter; L J Fairbairn
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

5.  Apurinic/apyrimidinic endonuclease 2 is necessary for normal B cell development and recovery of lymphoid progenitors after chemotherapeutic challenge.

Authors:  Jeroen E J Guikema; Rachel M Gerstein; Erin K Linehan; Erin K Cloherty; Eric Evan-Browning; Daisuke Tsuchimoto; Yusaku Nakabeppu; Carol E Schrader
Journal:  J Immunol       Date:  2011-01-12       Impact factor: 5.422

6.  Adult human circulating CD34⁻Lin⁻CD45⁻CD133⁻ cells can differentiate into hematopoietic and endothelial cells.

Authors:  Elisa Ciraci; Silvia Della Bella; Ombretta Salvucci; Cristina Rofani; Marta Segarra; Caterina Bason; Agnese Molinari; Dragan Maric; Giovanna Tosato; Anna C Berardi
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

7.  Temporal mapping of gene expression levels during the differentiation of individual primary hematopoietic cells.

Authors:  T Cheng; H Shen; D Giokas; J Gere; D G Tenen; D T Scadden
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

Review 8.  Modeling human hematopoietic stem cell biology in the mouse.

Authors:  Stephen M Sykes; David T Scadden
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

9.  P2Y-like receptor, GPR105 (P2Y14), identifies and mediates chemotaxis of bone-marrow hematopoietic stem cells.

Authors:  Byeong-Chel Lee; Tao Cheng; Gregor B Adams; Eyal C Attar; Nobuyuki Miura; Sean Bong Lee; Yoriko Saito; Ivona Olszak; David Dombkowski; Douglas P Olson; Julie Hancock; Peter S Choi; Daniel A Haber; Andrew D Luster; David T Scadden
Journal:  Genes Dev       Date:  2003-07-01       Impact factor: 11.361

10.  Thrombopoietin upregulates nucleolin mRNA and protein in thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.

Authors:  Takatoshi Ito; Mitsuhiro Fujihara; Atsushi Oda; Shinobu Wakamoto; Miki Yamaguchi; Norio Komatsu; Hiroshi Miyazaki; Hiroshi Azuma; Hisami Ikeda; Kenji Ikebuchi
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.